US equities |
SPCX $167.09 ▲+5.11% NVDA $236.37 ▲+1.03% MU $1,064.60 ▼-0.96% TSLA $378.45 ▲+2.12% MSFT $525.09 ▲+1.46% SNDK $1,709.68 ▼-0.60% INTC $117.47 ▼-1.56% META $743.30 ▲+2.09%
FinancialContent

MacroGenics, Inc. - Common Stock (NQ:MGNX)

3.675 +0.095 (+2.65%)
Delayed Quote Updated: 12:23 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
Which stocks are gapping on Tuesday? ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
A Look at Macrogenics's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring Macrogenics Through Analyst Insights ↗
 
Via Benzinga
News headline image
4 Analysts Assess Macrogenics: What You Need To Know ↗
 
Via Benzinga
News headline image
MacroGenics Announces Date of First Quarter 2025 Financial Results
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Macrogenics Earnings Preview ↗
 
Via Benzinga
News headline image
Macrogenics Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
News headline image
MacroGenics (MGNX) Q4 2024 Earnings Call Transcript ↗
MGNX earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For March 20, 2025 ↗
 
Via Benzinga
News headline image
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating Macrogenics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript ↗
MGNX earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
MacroGenics Announces Leadership Transition
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
News headline image
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
From TerSera Therapeutics LLC
Via Business Wire
News headline image
MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
MGNX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action – MGNX
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics
From Faruqi & Faruqi LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >